NICHOLAS YARROBINO: Open Payments
NPI 1770093635 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,585 in 108 payments from 43 companies in 2025. Trend: 2023 $2,567 · 2024 $5,054 · 2025 $2,585
Food & beverage: $2,465Education: $120
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $271 |
| Incyte Corporation | 9 | $213 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| ABBVIE INC. | 7 | $138 |
| ARRAY BIOPHARMA INC | 5 | $115 |
| Daiichi Sankyo Inc. | 5 | $113 |
| SOBI, INC | 4 | $105 |
| SEAGEN INC. | 1 | $100 |
| Aveo Pharmaceuticals, Inc. | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $79 |
Products named: RYBREVANT, JAKAFI, Doptelet, Epkinly, FOTIVDA, XALKORI, VENCLEXTA, LIBTAYO.
Industry payments across TX — which companies pay providers there.
